Erratum: Tanshinone IIA protects PC12 cells from β-amyloid25-35-induced apoptosis via PI3 K/Akt signaling pathway (Mol Biol Rep, (2012) 39, 6, (6495-6503), 10.1007/s11033-012-1477-3);Tanshinone IIA protects PC12 cells from β-amyloid25-35- induced apoptosis via PI3K/Akt signaling pathway

Molecular Biology Reports

Volumn 39, Issue 6, 2012, Pages 6495-6503

  Dong, Huimin ^a   Mao, Shanpin ^a   Wei, Jiajun ^a   Liu, Baohui ^a   Zhang, Zhaohui ^a   Zhang, Qian ^a   Yan, Mingmin ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Akt; Alzheimer's disease; Glycogen synthase kinase 3 ; Neuroprotection; PC12 cells; Tanshinone IIA

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; AMYLOID BETA PROTEIN[25-35]; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM CHLORIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TANSHINONE IIA;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL LOSS; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SCREENING; DRUG TARGETING; ENZYME PHOSPHORYLATION; INTRACELLULAR SIGNALING; MOLECULAR DYNAMICS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PROTEIN TARGETING; RAT;

RATTUS;

EID: 84864289127     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1618-8     Document Type: Erratum

References (41)

1. Kremer A, Louis JV, Jaworski T, Van Leuven F (2011) GSK3 and Alzheimer's disease: facts and fiction. Front Mol Neurosci 4:17
2. Zekanowski C, Wojda U (2009) Aneuploidy chromosomal mis-segregation, and cell cycle reentry in Alzheimer's disease. Acta Neurobiol Exp (Wars) 69:232-253
3. Bing Song, Korbin Davis X, Shawn Liu, Hyoung-gon Lee, Mark Smith, Xiaoqi Liu (2011) Inhibition of Polo-like kinase 1 reduces beta-amyloid-induced neuronal cell death in Alzheimer's disease. Aging (Albany NY) Epub ahead of print
4. Sun L, Guo C, Liu D, Zhao Y, Zhang Y, Song Z, Han H, Chen D, Zhao Y (2011) Protective effects of bone morphogenetic protein 7 against amyloid-beta induced neurotoxicity in PC12 cells. Neuroscience 184:151-163
5. Xing G, Dong M, Li X, Zou Y, Fan L, Wang X, Cai D, Li C, Zhou L, Liu J, Niu Y (2011) Neuroprotective effects of puerarin against beta-amyloid-induced neurotoxicity in PC12 cells via a PI3K-dependent signaling pathway. Brain Res Bull 85(3-4):212-218
6. Song JX, Lin X, Wong RN, Sze SC, Tong Y, Shaw PC, Zhang YB (2011) Protective effects of dibenzocyclooctadiene lignans from Schisandra chinensis against beta-amyloid and homocys-teine neurotoxicity in PC12 cells. Phytother Res 25(3):435-443
7. Liu X, Xu K, Yan M, Wang Y, Zheng X (2010) Protective effects of galantamine against Abeta-induced PC12 cell apoptosis by preventing mitochondrial dysfunction and endoplasmic reticulum stress. Neurochem Int 57(5):588-599
8. Phiel CJ, Wilson CA, Lee VM-Y, Klein PS (2003) GSK-3a regulates production of Alzheimer's disease amyloid-b peptides. Nature 423:435-439 (Pubitemid 36626994)
9. Jia Y, Huang F, Zhang S, Leung SW (2011) Is danshen (Salvia miltiorrhiza) dripping pill more effective than isosorbide dinitrate in treating angina pectoris? A systematic review of randomized controlled trials. Int J Cardiol Jan 18 Epub ahead of print
10. Imanshahidi M, Hosseinzadeh H (2006) The pharmacological effects of Salvia species on the central nervous system. Phytother Res 20:427-437 (Pubitemid 43953393)
11. Won SH, Lee HJ, Jeong SJ, Lee HJ, Lee EO, Jung DB, Shin JM, Kwon TR, Yun SM, Lee MH, Choi SH, Lü J, Kim SH (2010) Tan IIA induces mitochondria dependent apoptosis in prostate cancer cells in association with an inhibition of phosphoinositide 3-kinase/AKT pathway. Biol Pharm Bull 33:1828-1834
12. Lin HQ, Ho MT, Lau LS, Wong KK, Shaw PC, Wan DC (2008) Anti-acetylcholinesterase activities of traditional Chinese medicine for treating Alzheimer's disease. Chem Biol Inter 175:352-354
13. Liu T, Jin H, Sun QR, Xu JH, Hu HT (2010) The neuroprotective effects of tanshinone IIA on b-amyloid-induced toxicity in rat cortical neurons. Neuropharmacology 59(7-8):595-604
14. Wan J, Fu AK, Ip FC, Ng HK, Hugon J, Page G, Wang JH, Lai KO, Wu Z, Ip NY (2010) Tyk2/STAT3 signaling mediates beta-amyloid-induced neuronal cell death: implications in Alzheimer's disease. J Neurosci 30(20):6873-6881
15. Mines Marjelo A, Beurel Eleonore, Jope Richard S (2011) Regula-tionofcell survival mechanisms in Alzheimer's disease byglycogen synthase kinase-3. Int J Alzheimers Dis. doi:10.4061/2011/861072
16. Ma Rong, Xiong Nian, Huang Chengfang, Tang Qiang, Benrong Hu, Xiang Jizhou, Li Gang (2009) Erythropoietin protects PC12 cells from b-amyloid25-35-induced apoptosis via PI3K/Akt signaling pathway. Neuropharmacology 56:1027-1034
17. Tato I, Bartrons R, Ventura F, Rosa JL (2011) Amino acids activate mammalian target of rapamycin complex 2 (mTORC2) via PI3K/Akt signaling. J Biol Chem 286:6128-6142
18. Zhao R, Zhang Z, Song Y, Wang D, Qi J, Wen S (2011) Implication of phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase-3b pathway inginsenoside Rb1's attenuationof beta-amyloid-induced neurotoxicity and tau phosphorylation. J Ethnopharmacol 133: 1109-1116
19. Jarvis K, Assis-Nascimento P, Mudd LM, Montague JR (2007) Beta-amyloid toxicity and reversal in embryonic rat septal neurons. Neurosci Lett 423:184-188 (Pubitemid 47285476)
20. Sokol DK, Maloney B, Long JM, Ray B, Lahiri DK (2011) Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links. Neurology 76:1344-1352
21. Bonda DJ, Lee HG, Camins A, Pallàs M, Casadesus G, Smith MA, Zhu X (2011) The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations. Lancet Neurol 10:275-279
22. Amtul Z, Uhrig M, Beyreuther K (2011) Additive effects of fatty acid mixtures on the levels and ratio of amyloid b 40/42 peptides differ from the effects of individual fatty acids. J Neurosci Res. doi:10.1002/jnr.22706. Epub ahead of print
23. Hongpaisan J, Sun MK, Alkon DL (2011) PKC e activation prevents synaptic loss, A b elevation, and cognitive deficits in Alzheimer's disease transgenic mice. J Neurosci 31:630-643
24. Jawhar S, Wirths O, Schilling S, Graubner S, Demuth HU, Bayer TA (2011) Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate A{beta} formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD mice. J Biol Chem 286:4454-4460
25. Xi YD, Yu HL, Ma WW, Ding BJ, Ding J, Yuan LH, Feng JF, Xiao (2011) Genistein inhibits mitochondrial-targeted oxidative damage induced by beta-amyloid peptide 25-35 in PC12 cells. J Bioenerg Biomembr 43(4):399-407
26. Fu J, Huang H, Liu J, Pi R, Chen J, Liu P (2007) Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis. Eur J Pharmacol 568:213-221 (Pubitemid 46976900)
27. Lam BY, Lo AC, Sun X, Luo HW, Chung SK, Sucher NJ (2003) Neuroprotective effects of tanshinones in transient focal cerebral ischemia in mice. Phytomedicine 10:286-291 (Pubitemid 36597164)
28. Zhou L, Zuo Z, Chow MS (2005) Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 45:1345-1359 (Pubitemid 41643896)
29. Meng XF, Zou XJ, Peng B, Shi J, Guan XM, Zhang C (2006) Inhibition of ethanol-induced toxicity by tanshinone IIA in PC12 cells. Acta Pharmacol Sin 27(6):659-664 (Pubitemid 43943912)
30. Spillantini MG, Goedert M (1998) Tau protein pathology in neurodegenerative diseases. Trends Neurosci 21:428-433 (Pubitemid 28449072)
31. Lee VM, Goedert M, Trojanowski JQ (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24:1121-1159 (Pubitemid 32695256)
32. Geschwind DH, Miller BL (2001) Molecular approaches to cerebral laterality: development and neurodegeneration. Am J Med Genet 101:370-381 (Pubitemid 32591428)
33. Aparicio IM, Garcia-Herreros M, Fair T, Lonergan P (2010) Identification and regulation of glycogen synthase kinase-3 during bovine embryo development. Reproduction 140(1):83-92
34. Moore SF, Hunter RW, Hers I (2011) mTORC2-mediated Akt Ser473 phosphorylation is not required for Akt1 activity in human platelets. J Biol ChemMay 18. Epub ahead of print
35. Koide H, Asai T, Furuya K, Tsuzuku T, Kato H, Dewa T, Nango M, Maeda N, Oku N (2011) Inhibition of Akt (ser473) phos-phorylation and rapamycin-resistant cell growth by knockdown of mammalian target of rapamycin with small interfering RNA in vascular endothelial growth factor receptor-1-targeting vector. Biol Pharm Bull 34:602-608
36. Shi X, McGinty JF (2011) D1 and D2 dopamine receptors differentially mediate the activation of phosphoproteins in the stri-atum of amphetamine-sensitized rats. Psychopharmacology (Berl) 214:653-663
37. 3 receptors. Mol Pharmacol 79:91-105
38. Sánchez-Blázquez P, Rodríguez-Muñoz M, Garzón J (2010) Mu-opioid receptors transiently activate the Akt-nNOS pathway to produce sustained potentiation of PKC-mediated NMDAR-CaMKII signaling. PLoS One 5:e11278
39. Soriano FX, Papadia S, Hofmann F, Hardingham NR, Bading H, Hardingham GE (2006) Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability. J Neu-rosci 26:4509-4518 (Pubitemid 44315350)
40. Zhao R, Zhang Z, Song Y, Wang D, Qi J, Wen S (2011) Implication of phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase-3b pathway in ginsenoside Rb1's attenuation of beta-amyloid-induced neurotoxicity and tau phosphorylation. J Ethno-pharmacol 133(3):1109-1116
41. Beaulieu Jean-Martin, Gainetdinov Raul R, Caron Marc G (2009) Akt/GSK3 Signaling in the Action of Psychotropic Drugs. Annu Rev Pharmacol Toxicol 49:327-347